Daiichi Kigenso Kagaku Kogyo Past Earnings Performance
Past criteria checks 0/6
Daiichi Kigenso Kagaku Kogyo's earnings have been declining at an average annual rate of -8.4%, while the Chemicals industry saw earnings growing at 9.9% annually. Revenues have been growing at an average rate of 9.3% per year.
Key information
-8.4%
Earnings growth rate
-8.5%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 9.3% |
| Return on equity | -2.1% |
| Net Margin | -2.4% |
| Last Earnings Update | 30 Sep 2024 |
Revenue & Expenses Breakdown
How Daiichi Kigenso Kagaku Kogyo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 34,673 | -840 | 4,643 | 1,173 |
| 30 Jun 24 | 35,326 | 961 | 5,193 | 1,173 |
| 31 Mar 24 | 35,220 | 1,140 | 5,110 | 1,173 |
| 31 Dec 23 | 36,012 | 1,734 | 4,936 | 1,071 |
| 30 Sep 23 | 36,407 | 2,088 | 4,517 | 1,071 |
| 30 Jun 23 | 36,135 | 2,685 | 4,400 | 1,071 |
| 31 Mar 23 | 35,748 | 4,020 | 4,634 | 1,071 |
| 31 Dec 22 | 34,224 | 2,287 | 4,492 | 929 |
| 30 Sep 22 | 31,500 | 3,106 | 4,542 | 929 |
| 30 Jun 22 | 29,808 | 2,390 | 4,206 | 929 |
| 31 Mar 22 | 29,365 | 1,849 | 3,491 | 929 |
| 31 Dec 21 | 29,658 | 3,825 | 3,449 | 894 |
| 30 Sep 21 | 29,260 | 3,521 | 3,529 | 894 |
| 30 Jun 21 | 26,616 | 2,674 | 3,403 | 894 |
| 31 Mar 21 | 23,465 | 1,235 | 3,442 | 894 |
| 31 Dec 20 | 21,614 | 1,017 | 3,372 | 951 |
| 30 Sep 20 | 21,686 | 1,115 | 3,345 | 951 |
| 30 Jun 20 | 24,027 | 1,670 | 3,432 | 951 |
| 31 Mar 20 | 26,518 | 2,348 | 3,442 | 951 |
| 31 Dec 19 | 26,794 | 2,400 | 3,398 | 933 |
| 30 Sep 19 | 27,588 | 2,651 | 3,402 | 933 |
| 30 Jun 19 | 27,116 | 2,883 | 3,317 | 933 |
| 31 Mar 19 | 27,483 | 3,093 | 3,218 | 933 |
| 31 Dec 18 | 27,661 | 2,970 | 3,010 | 1,061 |
| 30 Sep 18 | 27,254 | 3,109 | 3,026 | 1,061 |
| 30 Jun 18 | 26,653 | 3,018 | 2,952 | 1,061 |
| 31 Mar 18 | 25,537 | 2,971 | 2,804 | 1,061 |
| 31 Dec 17 | 24,941 | 3,542 | 2,977 | 809 |
| 30 Sep 17 | 24,149 | 3,901 | 2,725 | 809 |
| 30 Jun 17 | 23,806 | 3,877 | 2,595 | 809 |
| 31 Mar 17 | 23,399 | 3,732 | 2,547 | 809 |
| 31 Dec 16 | 23,331 | 3,252 | 2,336 | 901 |
| 30 Sep 16 | 22,781 | 2,521 | 2,287 | 901 |
| 30 Jun 16 | 23,086 | 2,680 | 2,230 | 901 |
| 31 Mar 16 | 23,295 | 2,782 | 2,216 | 901 |
| 31 Dec 15 | 22,991 | 2,851 | 2,281 | 806 |
| 30 Sep 15 | 23,143 | 3,262 | 2,191 | 806 |
| 30 Jun 15 | 23,299 | 3,309 | 2,095 | 806 |
| 31 Mar 15 | 23,159 | 3,178 | 1,964 | 806 |
Quality Earnings: 4082 is currently unprofitable.
Growing Profit Margin: 4082 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4082 is unprofitable, and losses have increased over the past 5 years at a rate of 8.4% per year.
Accelerating Growth: Unable to compare 4082's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4082 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (14%).
Return on Equity
High ROE: 4082 has a negative Return on Equity (-2.11%), as it is currently unprofitable.